Clorox remains a durable branded-staples name, but flat revenue, higher debt, and a difficult ERP transition keep the stock in Hold territory. Household and International are improving, yet Fresh Step and Food remain key execution challenges.
The Clorox Company (CLX) is a durable branded-staples business trading near $97.37, but the investment case is balanced rather than aggressive. The company owns category leaders, generates strong operating cash flow, and carries a forward P/E of 15.8x. Against those strengths, revenue growth is only 0.1% year over year, debt increased to $4.2B after the GOJO acquisition, and management reduced fiscal 2026 guidance after a difficult ERP transition and higher supply-chain costs.
The central issue is execution. Q3 fiscal 2026 revenue was $1.67B, essentially flat year over year, while GAAP diluted EPS was $1.54 and adjusted EPS was $1.64. Household and International performed well, but Lifestyle revenue fell 9% and Health and Wellness segment EBIT fell 7%. Management said the ERP implementation is complete, which removes one major operational disruption, but Fresh Step litter is undergoing a multiyear reset and Food faces heavy discounting.
CLX suits a moderate-risk investor seeking branded consumer exposure, cash generation, and lower market sensitivity rather than rapid earnings expansion. The stock's beta is 0.5, institutional ownership is 86.3%, and the analyst consensus is concentrated in 13 Hold ratings and 2 Sell ratings. The appropriate stance is Hold, with an estimated fair value of $102.00.
The Clorox Company (CLX) manufactures and markets consumer and professional products across four segments: Health and Wellness, Household, Lifestyle, and International. The company generated $7.1B of fiscal 2025 revenue, employed about 7,600 people as of June 30, 2025, and sells through mass retailers, grocery stores, warehouse clubs, dollar stores, drugstores, pet stores, e-commerce channels, and distributors.
The portfolio includes Clorox cleaning and disinfecting products, Glad bags and wraps, Fresh Step and Scoop Away litter, Kingsford grilling products, Hidden Valley food products, Brita water filtration, Burt's Bees personal care, and professional hygiene products sold through CloroxPro, Clorox Healthcare, and the Purell business acquired from GOJO.
Brand concentration is a meaningful advantage. Clorox reports that about 80% of sales come from brands ranked No. 1 or No. 2 in their categories. That position gives the company valuable shelf access, but it does not eliminate retailer bargaining power. The five largest customers accounted for nearly half of consolidated sales in fiscal 2025, fiscal 2024, and fiscal 2023.
Health and Wellness is Clorox's largest segment. Fiscal 2025 revenue was $2.7B, or 38.2% of total revenue. Q3 fiscal 2026 revenue was $629M, essentially flat year over year, while adjusted EBIT declined 7% to $158M. Management identified higher manufacturing and logistics costs as the main pressure on profitability.
Household generated $2.0B of fiscal 2025 revenue, or 28.3% of the company total. Q3 revenue increased 3% to $482M, and adjusted EBIT rose 21% to $74M. The result benefited from higher volume, cost savings, and shipment timing in cat litter and grilling. Cleaning innovation also remains a strength within this segment.
Lifestyle produced $1.3B of fiscal 2025 revenue, or 18.4% of the total. Q3 revenue fell 9% to $277M, driven by lower consumption and retail inventory adjustments. Adjusted EBIT held at $60M because lower advertising and selling expenses offset the lower sales base. Hidden Valley's new product launches and revised bottle format are intended to restore share in a category facing mid-single-digit contraction.
International generated $1.1B of fiscal 2025 revenue, or 15.1% of the total. Q3 revenue increased 8% to $285M, including 2% organic growth, while adjusted EBIT rose 16% to $36M. Favorable foreign exchange and higher volume supported the result. International is smaller than the domestic businesses but currently provides one of the clearer pockets of growth.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The core Clorox cleaning franchise remains the most important product engine. Management called cleaning the company's biggest business and said it continued to win share despite a competitive promotional environment. The Clorox name carries particular value in disinfecting, where perceived efficacy and trust matter alongside price.
Clorox PURE is the most visible recent extension of that franchise. Management described the allergen platform as its largest innovation, with early distribution wins, preferred shelf placement, favorable reviews, and velocity above expectations. The product also creates access to new store sections rather than simply adding another version of an established cleaner.
Fresh Step is the portfolio's largest execution problem. Clorox changed product names, claims, pack sizes, and price-pack architecture during a broad reset that began rolling out at the end of Q3. Distribution gains were generally in line with plan, but some products reached the wrong shelf locations. Management described the recovery as a multiyear process, which limits the speed of any earnings payoff.
Hidden Valley is taking a more targeted route. Clorox returned its regular 16-ounce bottle to shelves after a prior format change and launched Avocado Oil, protein-forward options, YumYum Ranch, and Parmesan Ranch Seasoning. Management said Food returned to share growth in Q3, although the broader category declined closer to mid-single digits.
Clorox's competitive advantage rests on brand recognition, category leadership, and retail execution. About 80% of sales come from No. 1 or No. 2 brands, while Q3 total distribution points increased more than 5%. Those facts support a durable shelf presence that newer brands and store brands must work to displace.
The innovation pipeline is broad rather than dependent on one launch. It includes Clorox PURE, Scentiva scent extensions, new Glad absorbent layers, Kingsford Craftsmoke Pellets, Burt's Bees Lip Treats and skincare, and new Hidden Valley products. Management said Scentiva's Cherry Blossom scent became the company's top scent, while consumers continued to pay for premium experiences in several categories.
The limitation is that innovation requires advertising, trade spending, distribution, and accurate demand planning. Q3 advertising expense fell to $177M from $207M a year earlier, while gross margin declined to 43.2% from 44.6%. The brands have reach, but the return on that reach depends on converting distribution gains into sustained consumption.
The ERP transition was a major operating event. Management said the company spent the first half of fiscal 2026 implementing and stabilizing the new system, creating inventory and execution disruption. The implementation is now complete, which removes a direct operational drag, but the transition contributed approximately 7.5 points of fiscal 2026 sales pressure and about $0.90 of EPS pressure.
Supply-chain costs remain a more immediate concern. Management used a $100-per-barrel oil assumption for Q4 and estimated a $20M to $25M headwind, equal to about 130 basis points of gross margin. Q3 cost of products sold increased to $948M from $924M even though revenue was essentially flat.
Clorox is responding through revenue growth management, price-pack architecture, productivity, reformulation, supply-chain savings, and accelerated structural cost reductions. The company also reported that Q3 total distribution points increased more than 5%, although management is still correcting shelf placement for certain Fresh Step products. This combination shows that the supply chain is improving in reach but remains exposed to cost and execution volatility.
Clorox operates in large, recurring-consumption markets. Mordor Intelligence estimates the global household care market at $202.3B in 2026 and $262.5B by 2031, representing a 5.3% CAGR. The market includes surface cleaners, laundry care, dishwashing products, toilet care, air care, bleach, and related household products.
The strongest structural opportunities are premiumization, digital commerce, natural formulations, and convenience. Mordor Intelligence projects natural and organic products to grow at a 7.0% CAGR through 2031 and online retail stores at a 6.0% CAGR. Clorox's Free & Clear, Scentiva, Brita, Burt's Bees, and Clorox PURE products align with those specific market directions.
The market is mature, which changes the growth equation. Clorox does not need to create demand for cleaning, litter, bags, food products, or filtration, but it must take share, improve mix, or raise prices to grow faster than the underlying categories. Q3 results illustrate the tension: Household and International grew, while Lifestyle declined 9%.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Clorox serves households, professional customers, food-service operators, and international distributors. Its retail footprint covers mass merchants, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drugstores, pet stores, military stores, and e-commerce. That breadth supports repeat purchases, but the five largest customers account for nearly half of consolidated sales.
Management's Q3 comments point to a consumer who is pressured but still selective. Category demand was described as roughly flat to up 1% in aggregate, private-label share did not increase during the quarter, and consumers continued to buy branded innovation. Consumers also traded between larger and smaller sizes, which supports the value of flexible price-pack architecture.
The customer is not uniform across the portfolio. Food faced high promotional intensity and deep competitor discounting, while cleaning benefited from innovation and premium scent demand. Fresh Step customers are being mapped from legacy products to redesigned items. That transition creates a direct risk that distribution gains do not immediately translate into repeat purchase.
Clorox competes with Procter & Gamble (PG), Reckitt, Church & Dwight (CHD), SC Johnson, Henkel, Colgate-Palmolive (CL), and private-label brands. Competition is based on performance, price, brand reputation, image, and promotion. Clorox's No. 1 or No. 2 position in about 80% of sales provides an important defense, but store brands remain a structural threat in cleaners, bags, wipes, and litter.
Clorox's narrower $7.1B revenue base makes category execution more important than it is for a larger diversified consumer-products company. A weak litter reset or a sharp Food decline can affect the consolidated growth rate quickly. Conversely, a successful cleaning platform or stronger International performance can have an outsized effect on the earnings narrative.
GOJO adds a new competitive dimension. The Purell business contributes about $800M of annual revenue, has a history of mid-single-digit growth, and carries a professional, business-to-business mix. Management expects at least $50M of run-rate cost synergies over time, although the acquisition also adds debt and initially dilutes gross margin by about 50 basis points.
Oil and logistics costs are the clearest near-term macro pressure. Management tied a $100-per-barrel Q4 oil assumption to a $20M to $25M cost headwind and 130 basis points of gross-margin pressure. The company is using pricing, productivity, reformulation, and supply-chain actions to offset higher input costs, but the Q4 estimate captures the cost before those mitigations are fully deployed.
International operations add foreign-exchange and geopolitical exposure. International Q3 sales rose 8%, helped by favorable FX, while management also referred to disruptions around the world. The 10-K identifies tariffs, commodity prices, foreign exchange, and international production risks as factors that can affect sales, margins, and cash flow.
Operational resilience is another material risk. The 10-K discusses a prior cyberattack and the potential for cybersecurity incidents to disrupt operations. It also reports a $27M environmental remediation liability as of June 30, 2025 and notes that the company handles hazardous substances, including chlorine, at some international facilities.
Debt rose to $4.2B after the GOJO acquisition, and the company’s balance sheet now has less room for error even as operating cash flow remains strong.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q3 fiscal 2026 revenue was $1.67B with GAAP EPS of $1.54 and adjusted EPS of $1.64, but Lifestyle fell 9% and Health and Wellness EBIT dropped 7%.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management cut fiscal 2026 guidance after the ERP transition and higher supply-chain costs, signaling that earnings recovery will depend on cleaner execution ahead.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At 15.8x forward earnings, CLX trades at a reasonable multiple for a defensive consumer name, but the market is already discounting the company’s slow growth.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →With a fair value of $102 and the stock near $97.37, CLX sits close to the analyst midpoint, leaving limited near-term upside under a Hold view.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The Clorox Company (CLX) remains a credible branded-staples franchise, but the stock is not a clean turnaround bet. Fiscal 2025 produced $810M of net income, $981M of operating cash flow, and a 45.2% gross margin. Q3 fiscal 2026 then showed flat revenue, lower gross margin, strong Household and International performance, and continued pressure in Lifestyle and Health and Wellness.
The completed ERP implementation, Clorox PURE platform, improved distribution, and GOJO integration provide identifiable recovery drivers. The counterweights are equally concrete: fiscal 2026 guidance was reduced, Fresh Step requires a multiyear reset, oil-related costs could remove $20M to $25M from Q4 results, and quarterly debt reached $4.2B after the acquisition.
At $97.37, CLX is close to the report's $102.00 fair value estimate. That limited gap supports a Hold rather than a Buy. A lower entry price would better compensate for execution and leverage risk, while a higher price would require the gradual earnings recovery already embedded in the longer-term estimates.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Clorox rebuilt profitability in fiscal 2025, but FY2026 guidance was cut sharply as ERP-related inventory drawdown hit sales and margins. The stock looks like a steady staples franchise in repair, with valuation close to fair and upside tied to execution.
The Clorox Company (CLX) drops sharply after cutting full-year profit guidance and warning that gross margins will weaken more than expected. The consumer staples name posted a mixed quarter, but investors are focusing on lower earnings power, margin pressure, and a tougher near-term outlook.
PDD Holdings Inc. (PDD) fell 5.05% as investors pulled back from China-linked e-commerce stocks. The move appears tied to tariff and policy concerns around Temu rather than a company-specific earnings or filing update. Valuation looks cheap, but recent earnings misses keep the stock under pressure.